Erratum to: Growth of hepatocellular carcinoma in the regenerating liver (Liver Transplantation, (2011), 17, 7, (866-874), 10.1002/lt.22325);Growth of hepatocellular carcinoma in the regenerating liver

Liver Transplantation

Volumn 17, Issue 7, 2011, Pages 866-874

  Shi, Ji Hua ^a,b,c   Huitfeldt, Henrik S ^a   Suo, Zhen He ^a   Line, Pãl Dag ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Surgical Department   (Norway)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA TUBULIN; CALPAIN; CALPAIN SMALL SUBUNIT 1; CD34 ANTIGEN; CYCLIN D1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CADAVER DONOR; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CONTROLLED STUDY; LIVER CELL CARCINOMA; LIVER REGENERATION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; OCCULT CANCER; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 79959857459     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.25706     Document Type: Erratum

References (45)

1. Llovet JM, Burroughs A, Bruix J,. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917. (Pubitemid 37518510)
2. Rampone B, Schiavone B, Martino A, Viviano C, Confuorto G,. Current management strategy of hepatocellular carcinoma. World J Gastroenterol 2009; 15: 3210-3216.
3. Bismuth H, Chiche L, Castaing D,. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995; 19: 35-41.
4. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
5. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, et al. Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990; 65: 1104-1110. (Pubitemid 20072042)
6. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J,. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78-86. (Pubitemid 46142736)
7. Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, et al. Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 2009; 15: 1861-1866.
8. Adam R,. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 2003; 14 (suppl 2): ii13-ii16. (Pubitemid 36874133)
9. Kemeny N,. Management of liver metastases from colorectal cancer. Oncology (Williston Park) 2006; 20: 1161-1176.
10. Llovet JM, Fuster J, Bruix J,. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440.
11. Sala M, Fuster J, Llovet JM, Navasa M, Solé M, Varela M,; for Barcelona Clinic Liver Cancer (BCLC) Group. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl 2004; 10: 1294-1300. (Pubitemid 39406086)
12. Man K, Ng KT, Lo CM, Ho JW, Sun BS, Sun CK, et al. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastasesâ activation of cell invasion and migration pathways. Liver Transpl 2007; 13: 1669-1677.
13. Man K, Lo CM, Xiao JW, Ng KT, Sun BS, Ng IO, et al. The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg 2008; 247: 1049-1057. (Pubitemid 351770427)
14. Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Harimaya Y, et al. Increased surgical stress promotes tumor metastasis. Surgery 2003; 133: 547-555. (Pubitemid 36638227)
15. de Jong KP, Lont HE, Bijma AM, Brouwers MA, de Vries EG, van Veen ML, et al. The effect of partial hepatectomy on tumor growth in rats: in vivo and in vitro studies. Hepatology 1995; 22 (pt 1): 1263-1272.
16. Panis Y, Ribeiro J, Chrétien Y, Nordlinger B,. Dormant liver metastases: an experimental study. Br J Surg 1992; 79: 221-223.
17. Picardo A, Karpoff HM, Ng B, Lee J, Brennan MF, Fong Y,. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 1998; 124: 57-64. (Pubitemid 28354686)
18. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M,. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169: 28-34.
19. Higgins GM, Anderson RM,. Experimental pathology of the liver I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186-202.
20. Madrahimov N, Dirsch O, Broelsch C, Dahmen U,. Marginal hepatectomy in the rat: from anatomy to surgery. Ann Surg 2006; 244: 89-98. (Pubitemid 44297452)
21. Rodríguez G, Lorente L, Durán HJ, Aller MA, Arias J,. A 70% hepatectomy in the rat using a microsurgical technique. Int Surg 1999; 84: 135-138.
22. Okubo H, Takei Y, Serizawa N, Enomoto N, Ikejima K, Sato N,. Orthotopic hepatocellular carcinoma model with a controlled and reproducible tumorigenicity. J Gastroenterol Hepatol 2007; 22: 423-428. (Pubitemid 46238775)
23. Suo Z, Bjaamer A, Ottestad L, Nesland JM,. Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast. Ultrastruct Pathol 2001 Sep-Oct; 25 (5): 349-356. (Pubitemid 33116433)
24. Skarpen E, Lindeman B, Thoresen GH, Guren TK, Oksvold MP, Christoffersen T, Huitfeldt HS,. Impaired nuclear accumulation and shortened phosphorylation of ERK after growth factor stimulation in cultured hepatocytes from rats exposed to 2-acetylaminofluorene. Mol Carcinog 2000; 28: 84-96. (Pubitemid 30432476)
25. Fausto N, Laird AD, Webber EM,. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995; 9: 1527-1536.
26. Kren BT, Trembley JH, Fan G, Steer CJ,. Molecular regulation of liver regeneration. Ann N Y Acad Sci 1997; 831: 361-381. (Pubitemid 28045291)
27. Ramadori G, Armbrust T,. Cytokines in the liver. Eur J Gastroenterol Hepatol 2001; 13: 777-784. (Pubitemid 32656590)
28. Taub R,. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836-847. (Pubitemid 39336277)
29. Moolten FL, Bucher NL,. Regeneration of rat liver: transfer of humoral agent by cross circulation. Science 1967; 158: 272-274.
30. Budhu A, Wang XW,. The role of cytokines in hepatocellular carcinoma. J Leukoc Biol 2006; 80: 1197-1213. (Pubitemid 44904957)
31. Höpfner M, Schuppan D, Scherübl H,. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. World J Gastroenterol 2008; 14: 1-14. (Pubitemid 351314320)
32. Rabes HM,. Kinetics of hepatocellular proliferation after partial resection of the liver. Prog Liver Dis 1976; 5: 83-99.
33. Weinbren K, Woodward E,. Delayed incorporation of 32P from orthophosphate into deoxyribonucleic acid of rat liver after subtotal hepatectomy. Br J Exp Pathol 1964; 45: 442-449.
34. Bucher NL,. Experimental aspects of hepatic regeneration. N Engl J Med 1967; 277: 738-746.
35. Zieve L, Anderson WR, Lindblad S,. Course of hepatic regeneration after 80% to 90% resection of normal rat liver. Comparison with two-lobe and one-lobe hepatectomy. J Lab Clin Med 1985; 105: 331-336. (Pubitemid 16239755)
36. Kinoshita S, Hirai R, Yamano T, Yuasa I, Tsukuda K, Shimizu N,. Angiogenesis inhibitor TNP-470 can suppress hepatocellular carcinoma growth without retarding liver regeneration after partial hepatectomy. Surg Today 2004; 34: 40-46. (Pubitemid 38067892)
37. Mugitani T, Taniguchi H, Koishi Y, Masuyama M, Tanaka H, Koyama H, et al. Effects of angiogenesis inhibitor TNP-470 to suppress the recurrence in the liver remnant after partial hepatectomy for liver metastases in rabbits [in Japanese]. Gan To Kagaku Ryoho 1995; 22: 1477-1479.
38. Drixler TA, Vogten MJ, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE, Borel Rinkes IH,. Liver regeneration is an angiogenesis-associated phenomenon. Ann Surg 2002; 236: 703-711.
39. Ronco MT, Francés D, de Luján Alvarez M, Quiroga A, Monti J, Parody JP, et al. Vascular endothelial growth factor and nitric oxide in rat liver regeneration. Life Sci 2007; 81: 750-755. (Pubitemid 47285196)
40. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M,. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001; 49: 121-130.
41. Goll DE, Thompson VF, Li H, Wei W, Cong J,. The calpain system. Physiol Rev 2003; 83: 731-801. (Pubitemid 36828925)
42. Franco SJ, Huttenlocher A,. Regulating cell migration: calpains make the cut. J Cell Sci 2005; 118 (pt 17): 3829-3838. (Pubitemid 41410267)
43. Arthur JS, Greer PA, Elce JS,. Structure of the mouse calpain small subunit gene. Biochim Biophys Acta 1998; 1388: 247-252. (Pubitemid 28468624)
44. Tan Y, Dourdin N, Wu C, De Veyra T, Elce JS, Greer PA,. Conditional disruption of ubiquitous calpains in the mouse. Genesis 2006; 44: 297-303.
45. Bai DS, Dai Z, Zhou J, Liu YK, Qiu SJ, Tan CJ, et al. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology 2009; 49: 460-470.